Northpond Ventures GP, LLC - Jun 22, 2021 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role
10%+ Owner
Signature
Northpond Ventures GP, LLC, By: /s/ Patrick Smerkers, Senior Vice President, Finance and Operations
Stock symbol
TBIO
Transactions as of
Jun 22, 2021
Transactions value $
$7,500,000
Form type
4
Date filed
6/24/2021, 04:34 PM
Previous filing
Jun 17, 2021
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction TBIO Common Stock +Conversion of derivative security +9,375,380 9,375,380 Jun 22, 2021 By: Northpond Ventures, LP F1, F2
transaction TBIO Common Stock +Buy $7,500,000 +468,750 +5% $16.00 9,844,130 Jun 22, 2021 By: Northpond Ventures II, LP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Series A Preferred Stock -Conversion of derivative security -5,214,851 -100% 0 Jun 22, 2021 Common Stock 5,241,851 By: Northpond Ventures, LP F1, F2
transaction TBIO Series A-1 Preferred Stock -Conversion of derivative security -4,160,529 -100% 0 Jun 22, 2021 Common Stock 4,160,529 By: Northpond Ventures, LP F1, F2

Explanation of Responses:

Id Content
F1 Upon the closing of the initial public offering of Codex DNA, Inc. (the "Issuer"), each share of Class A Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), of the Issuer and each share of Class A-1 Preferred stock, par value $0.0001 per share of the Issuer (the "Series A-1 Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series A Preferred Stock and Series A-1 Preferred Stock into Common Stock had no expiration date.
F2 Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F3 Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.